This is a working overview of REV-ERB agonist, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-10-22. Anything still debated is marked as such rather than presented as settled.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for research-grade material |
| Solubility | Soluble in DMSO and ethanol; low aqueous solubility | Organic stock solutions are common |
| Typical storage temperature | -20 °C or lower | Protect from light and moisture |
| Common analytical method | LC-MS/MS | Used for detection and confirmation |
| Common synonyms | SR9009; Stenabolic | Stenabolic is an informal name |
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
20983Bi + 5424Cr → 262107Bh + n This discovery was further substantiated by their detailed measurements of the alpha decay chain of the produced bohrium atoms to previously known isotopes of fermium and californium. The IUPAC/IUPAP Transfermium Working Group (TWG) recognised the GSI collaboration as official discoverers in their 1992 report.
== History == Precursor drugs to repaglinide were invented in late 1983 by scientists at Dr Karl Thomae GmbH, a German drug manufacturer located at Biberach an der Riß in southern Germany which was acquired by Boehringer Ingelheim in 1990. The drug that became repaglinide was later licensed by Boehringer to Novo Nordisk, which filed an Investigational New Drug application for the compound with the Food and Drug Administration (FDA) in April 1992. Novo Nordisk filed its New Drug Application (NDA) for Prandin in July 1997 and it was quickly approved, gaining FDA approval in December 1997. The drug was the first of the meglitinide class. It was branded Prandin because its quick onset and short duration of action concentrates its effect around meal time (the prandium was the Roman meal which is comparable to the modern lunch).
He claimed that on 3 August the third side began to participate in the clashes between the Georgian and South Ossetian forces, firing on both the Georgians and South Ossetians. Illarionov said that the Ossetians do not deny the Georgian reports that the Ossetians violated the ceasefire declared on 7 August by Saakashvili. According to him, by August 2008 South Ossetia had become the most militarised territory per capita in the world, surpassing even North Korea. He also said that the Georgians apparently did not have any plan to invade South Ossetia, only a plan to defend the Georgian villages in South Ossetia. In November 2008, Russian organisation Memorial said there was abundant evidence of mutual shelling before 7 August 2008. The head of Memorial, Oleg Orlov, was in South Ossetia and Georgia for two weeks. He said that firing started on August 1 along the Georgian-South Ossetian border. Orlov said that South Ossetians had attacked Georgian civilians inside South Ossetia and they had used the Tskhinvali headquarters of Russian peacekeeping force as their base. Orlov said that Russia had provoked the Georgian military operation. He added, "But Russian peacekeepers also didn't do their job properly. We know the Russian side gave arms to the Ossetians and that they used them to fire towards Georgia from Russian peacekeeping positions well before August 7." Orlov reported that Russia had begun building the road connecting Tskhinvali with Akhalgori in the spring 2008, long before the war, and it was already completely finished.
Validation: Ensuring that the device meets the needs and requirements of its intended users and the intended use environment. Verification: Ensuring that the device meets its specified design requirements ISO 9001:2015 (Quality management systems requirements) makes the following distinction between the two activities, when describing design and development controls:
Tiagabine enhances the power of cortical delta (< 4 Hz) oscillations up to 1,000% relative to placebo, which may result in an EEG or MEG signature resembling non-rapid eye movement (NREM) sleep even while the person who has taken tiagabine is awake and conscious. This demonstrates that cortical delta activity and wakeful consciousness are not mutually exclusive, i.e., high amplitude delta oscillations are not always a reliable indicator of unconsciousness.
Sources: en.wikipedia.org
In June 2020, the Serum Institute of India (SII) – a major manufacturer of global vaccines – reached a licensing agreement with AstraZeneca to make 1 billion doses of vaccine for low-and-middle income countries, of which half of the doses would go to India. Similar preferential homeland distribution may exist if a vaccine is manufactured in Australia.
==== F ==== Fesikh – a traditional Egyptian fish dish consisting of fermented salted and dried gray mullet, of the mugil family, a saltwater fish that lives in both the Mediterranean and the Red Seas.
Satellite phone (satphone) – a portable wireless telephone similar to a cell phone, connected to the telephone network through a radio link to an orbiting communications satellite instead of through cell towers. They are more expensive than cell phones; but their advantage is that, unlike a cell phone which is limited to areas covered by cell towers, satphones can be used over most or all of the geographical area of the Earth. In order for the phone to communicate with a satellite using a small omnidirectional antenna, first-generation systems use satellites in low Earth orbit, about 400–700 miles (640–1,100 km) above the surface. With an orbital period of about 100 minutes, a satellite can only be in view of a phone for about 4 – 15 minutes, so the call is "handed off" to another satellite when one passes beyond the local horizon. Therefore, large numbers of satellites, about 40 to 70, are required to ensure that at least one satellite is in view continuously from each point on Earth. Other satphone systems use satellites in geostationary orbit in which only a few satellites are needed, but these cannot be used at high latitudes because of terrestrial interference. Cordless phone – a landline telephone in which the handset is portable and communicates with the rest of the phone by a short-range full duplex radio link, instead of being attached by a cord. Both the handset and the base station have low-power radio transceivers that handle the short-range bidirectional radio link. As of 2022, cordless phones in most nations use the DECT transmission standard.
receptor A protein which initiates a cellular response to an external stimulus or propagates a molecular signal by binding a specific ligand, often a dedicated signaling molecule. Numerous types of receptors exist which serve an enormous variety of functions. Cell-surface receptors, such as those that bind acetylcholine and insulin, are embedded within the cell membrane with their binding sites exposed to the extracellular space; intracellular receptors, including many hormone receptors, are located in the cytoplasm, where they bind ligands that have diffused across the membrane and into the cell.
Sources: en.wikipedia.org
Research-grade SR9009 is typically stored frozen at about minus twenty degrees Celsius, protected from light and moisture. Stock solutions are often kept in aliquots to avoid repeated freeze-thaw cycles. Specific storage conditions should follow the supplier's documentation.
Liquid chromatography with tandem mass spectrometry is widely used to detect and confirm SR9009 in laboratory samples. The technique offers high sensitivity and can distinguish the target compound from related substances. Nuclear magnetic resonance and ultraviolet detection may support identity and purity checks.
Online products labeled as SR9009 may vary in identity, purity, and actual content. Independent testing helps confirm that a sample matches its label and does not contain unexpected contaminants. This is important for reproducible research and for interpreting experimental results.
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.